Coronavirus channel feed

Ax­cel­la seeks 'light speed' swing at long Covid, but needs cash

3 years ago
R&D

FDA hopes to sim­pli­fy and stan­dard­ize Covid shots with­out mak­ing them in­ter­change­able

3 years ago
FDA+

Is­rael, EU drug reg­u­la­tors find no link be­tween Pfiz­er Covid shot and stroke

3 years ago
R&D

US in­ves­ti­gates po­ten­tial safe­ty sig­nal with Pfiz­er Covid boost­ers

3 years ago
Pharma
FDA+

Next-gen Covid vac­cines: No more quick vari­ant up­dates and RCTs may be re­quired, CBER leader writes

3 years ago
FDA+

Up­dat­ed: Mod­er­na rounds out 2022 with $18.4B in vac­cine sales, boosts R&D bud­get for 2023

3 years ago
Pharma

New year, new CEOs for Covid vac­cine mak­ers Cure­Vac and No­vavax

3 years ago

Scoop: To fund Covid-19 nasal vac­cine boost­er, Yale spin­out snags Se­ries A

3 years ago
Financing
Startups

Ever­est Med­i­cines be­gins pro­duc­tion at its new $129M+ mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty in Chi­na

3 years ago
Manufacturing

Roche's Actem­ra wins ap­proval for hos­pi­tal­ized Covid pa­tients

3 years ago
Pharma
FDA+

Up­dat­ed: BioN­Tech sends mR­NA Covid-19 vac­cines to Chi­na for 20,000 ex­pats

3 years ago

CBER's Pe­ter Marks says Covid-19 shots to mir­ror flu shots: Man­u­fac­tur­ers will be in­ter­change­able

3 years ago
FDA+

Ax­cel­la re­duces work­force by 85%, pri­or­i­tizes long Covid drug re­search

3 years ago

Pfiz­er's plan for $110+ Covid-19 vac­cines riles up US sen­a­tors

3 years ago

FDA au­tho­rizes bi­va­lent Covid boost­ers for chil­dren 6 months and up

3 years ago
Pharma
FDA+

Pfiz­er and BioN­Tech look to toss Mod­er­na patent suit, call­ing claims 'unen­force­able'

3 years ago
Pharma
Law

US sup­ports ex­ten­sion for Covid-19 IP waiv­er de­ci­sion

3 years ago
R&D

Lil­ly's Covid-19 mAb no longer au­tho­rized due to Omi­cron sub­vari­ants, FDA says

3 years ago

Sh­ionogi's Covid an­tivi­ral lands first ap­proval in Japan's new emer­gency ap­proval path­way

3 years ago
R&D

No­vavax pulls out of Covid-19 vac­cine al­liance with Gavi

3 years ago
Pharma

Biden forges new $475M cam­paign to dri­ve up­take of Pfiz­er and Mod­er­na's bi­va­lent Covid vac­cines

3 years ago

CDC sur­vey re­veals Covid-19 vac­ci­na­tion rates for chil­dren re­main low

3 years ago
Pharma

Pfiz­er and BioN­Tech roll out new da­ta for their bi­va­lent boost­er against new­er Omi­cron vari­ants

3 years ago
R&D
Pharma

As bi­va­lent boost­er up­take crawls, Pfiz­er and BioN­Tech start ear­ly-stage pan-vari­ant tri­al

3 years ago
First page Previous page 2345678 Next page Last page
A service from the Financial Times